Jobs from the company:
Page 1 / 1
Previous
Next
21-100
FTE
Catalym is at the forefront of developing groundbreaking immunotherapies aimed at revolutionizing cancer treatment. By harnessing the body’s own immune system, they strive to effectively combat malignancies, enhancing the quality of life for cancer patients. Their commitment to innovation positions them as leaders in the biotech sector, particularly in oncology.
€236M
Munich
B2B
21-100
07/2024
Growth
38%
769%
Page 1 / 1